EPO: T 1727/12, European Patent Office, Board of Appeal, Publication Number: 1767375, 1 February 2016
The Board of Appeal held that “Biogen insufficiency”, the situation in which the full extent of the monopoly claimed exceeds the technical contribution to the art, is not a distinct ground for invalidity from “classical insufficiency”. Further, the fact that a skilled person is not able to carry out the invention without using the disclosed…